Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DCN1 inhibitors(Defective cullin neddylation protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H47N5O4S |
InChIKeyVHEFAXHJOOQBTB-RRPNLBNLSA-N |
CAS Registry2247060-97-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemical and Drug Induced Liver Injury | Preclinical | US | 11 Apr 2021 |